Profile: Raymedica, LLC specializes in the design, development and manufacturing of spinal products for orthopedic markets. Our product line includes PDN-solo and PDN-solo XL prosthetic disc nucleus device, hydraflex prosthetic disc nucleus devices and nucleus arthroplasty motion preservation technology. Our PDN-solo XL prosthetic disc nucleus device helps in the replacement of the nucleus of a diseased lumbar disc. Our nucleus arthroplasty motion preservation technology is used when the conservative treatment fails and for patients with early degenerative disc disease. Our nucleus arthroplasty system is developed through nucleus arthroplasty motion preservation technology which is utilized for the treatment of degenerative disc disease, disc herniations and post-operative rehabilitation.

The company was founded in 1991, has revenues of < USD 1 Million, has ~20 employees.